HeliTrax   FAQ   Contact Us   Forward to a Friend   
      

Hemophilia A patients who use Helixate® FS, Antihemophilic Factor (Recombinant), and their treatment providers can now track treatment progress in real time, with the HeliTraxSM System, a state-of-the-art wireless Internet-based data management system. The system allows for a comprehensive view of a patient's progress, with young patients relaying information about bleeding events and their use of Helixate® FS to their hemophilia treatment center via the handheld device or web interface between office visits. The HeliTraxSM System, used in conjunction with Helixate® FS treatment, is designed to improve patient-physician communications and therapy management.

Physicians monitoring hemophilia A patients often rely on paper forms filled out by the patients or their caregivers, which do not always provide necessary clinical information in a timely, clear and concise way. HeliTraxSM not only tracks a patient's therapy as it happens — including medication usage and inventory — but allows the hemophilia treatment center to generate a one-page, easy-to-read, full-color clinical report of the patient's progress. These private, secure reports, which help reduce documentation and transcription errors, are compliant with both the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the Health Insurance Portability and Accountability Act (HIPAA).

"I love it. As complicated as things are when you have a child with hemophilia, the HeliTraxSM System just makes life 150 percent easier."
- Shirley Smith, Hariman, Tennessee

"HeliTraxSM provides clinicians with the rapid, comprehensive clinical view they need to make assessments about treatment, it eliminates paperwork and helps to streamline patient data management. For young patients, HeliTraxSM helps them keep in touch with their therapy and motivates them to stay on track."
- Jill Leone, RN, CCRP, Hematology Nurse

For Healthcare Professionals      For Patients